SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-007911
Filing Date
2022-10-25
Accepted
2022-10-25 15:47:25
Documents
14
Period of Report
2022-10-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ivbt_8k.htm   iXBRL 8-K 21365
  Complete submission text file 0001477932-22-007911.txt   133485

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ivbt-20221019.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivbt-20221019_lab.xml EX-101.LAB 13171
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ivbt-20221019_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivbt-20221019_pre.xml EX-101.PRE 8249
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ivbt-20221019_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT ivbt_8k_htm.xml XML 3279
Mailing Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005
Business Address 40 WALL STREET, SUITE 2701 NEW YORK NY 10005 640-380-1923
Innovation1 Biotech Inc. (Filer) CIK: 0001629205 (see all company filings)

IRS No.: 822275255 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-55852 | Film No.: 221329425
SIC: 2834 Pharmaceutical Preparations